Thai PBS Thai PBS
Exoskeleton for stroke rehab cleared by U.S. regulators

Exoskeleton for stroke rehab cleared by U.S. regulators

12 Sept 05:01 Key points summarised by AI
  • U.S. regulators (FDA) cleared Wandercraft's self-balancing 'Atalante' exoskeleton for stroke rehabilitation, marking a significant advancement in assistive technology.
  • The exoskeleton empowers users to move hands-free in multiple directions, fostering independence for individuals with neurological conditions and disabilities.
  • Wandercraft plans to deploy the first Atalante exoskeletons in the United States during Q1 2023, following 22 successful deployments in clinical settings across Europe and the U.S. since 2020.
  • This innovation addresses a critical need, as stroke is a leading cause of long-term disability, offering hope for improved mobility and potentially reducing reliance on wheelchairs.
  • Currently sold to hospitals for rehabilitation, the company aims to develop lighter, personal versions for everyday use by private individuals in the future.
Read full article
Science & Technology 1/1
Skip > Skip >